Sector consensus GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
12:05:07 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,999.70 INR | -1.08% |
|
+12.45% | +21.27% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,310.9 | +2.39% | 28 | ||||||
| 272.5 | -0.33% | 22 | ||||||
| 276.59 | +3.99% | 29 | ||||||
| 370.31 | +0.79% | 18 | ||||||
| 154.11 | -2.89% | 21 | ||||||
| 212.3 | +29.47% | 22 | ||||||
| 388.48 | -12.18% | 29 | ||||||
| 313.7 | +4.76% | 24 | ||||||
| 157.41 | +6.64% | 27 | ||||||
| 28.61 | +1.3% | 26 | ||||||
| 563.12 | +2% | 25 | ||||||
| 66.21 | -2.07% | 24 | ||||||
| 94.28 | +20.01% | 23 | ||||||
| 21.61 | +12.8% | 20 | ||||||
| 9,350 | +35.8% | 15 | ||||||
| 6,450.19 | +11.81% | 16 | ||||||
| 56.83 | +15.96% | 18 | ||||||
| 79.25 | +50.5% | 16 | ||||||
| 41.4 | +10.49% | 10 | ||||||
| Average | 1,063.57 | +10.07% | 22 | ||||||
| Weighted average by Cap. | 711.98 | +4.53% | 24 |
Select your edition
All financial news and data tailored to specific country editions
